MTA1 Antibodies

Santa Cruz Biotechnology provides a broad selection of MTA1 Antibodies for research focused on understanding Metastasis-associated protein 1 (MTA1). MTA1 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). MTA1 functions as a crucial component of the NuRD complex, which is involved in chromatin remodeling and transcriptional regulation. Research has shown that MTA1 plays a significant role in cancer progression and metastasis, making it an important target for therapeutic research. Understanding MTA1 function can provide insights into tumor biology and potential treatment strategies. Ongoing studies continue to reveal new aspects of MTA1's involvement in cellular processes and disease mechanisms. Recent findings highlight MTA1's influence on cell signaling pathways and gene expression patterns. Researchers investigating cancer biology and therapeutic development can advance their work using Santa Cruz Biotechnology monoclonal antibodies, contributing to breakthrough discoveries in cancer research and treatment.